SRF and breast cancer: Furthermore, the ability to predict poor prognosis in BC patients with MCM1 expression was significant for three miRNAs: hsa-miR-760 (p value = 0.000825), hsa-miR-1224-5p (p value = 0.0135), and hsa-miR-4739 (p value = 0.0368) (Figure 10(a)).